Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
In brief: This is a multicenter, randomized, non-comparative, phase II proof-of-concept trial involved patients with progressive vitiligo and uses one of the most common regimens in this phase of study. Assessment of the experimental treatment efficacy will be estimated only on the results obtained in the experimental treatment arm (baricitinib 4 mg/day + narrowband UVB TL01 arm).
Ages eligible: 18 Years to 75 Years
Start date: May 1, 2021
Completion date (estimated): November 30, 2023
Location: Hôpital Saint-André, Bordeaux, France
Status: Active, recruiting
Contact: To learn more about this study, you or your doctor may contact Dr. Julien SENESCHAL at +33 (0)5 56 79 47 05 or julien.seneschal@chu-bordeaux.fr
Please refer to this study by its ClinicalTrials.gov identifier NCT04822584
FAQOther Questions
- What causes vitiligo?
Surprisingly, the causes of vitiligo are yet to be precisely established. Researchers know the cause is pre-wired in your genes, just waiting for a bad luck moment. In about hal...
- Is there a link between vitiligo and depression?
Yes, depression and anxiety often occur alongside vitiligo and can greatly affect a person's quality of life. The connection comes from the fact that both the skin and brain dev...
- Is it possible to stop the progression of vitiligo?
The best way to stop the progression of vitiligo before initiating repigmentation therapy is through the use of oral corticosteroids or immunosuppressive drugs. Specifically: ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.